For the initial treatment of venous thromboembolism: are all low-molecular-weight heparin compounds the same?

Abstract

Low-molecular-weight heparin compounds have been used in the treatment of patients with venous thromboembolism for approximately 15 years. Ever since their introduction, there has been discussion about whether low-molecular-weight heparin compounds differ in their efficacy and safety. The best answer would be provided by direct comparison of different low… (More)

Topics

  • Presentations referencing similar topics